Does ADALIMUMAB Cause Pulmonary embolism? 1,663 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,663 reports of Pulmonary embolism have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.3% of all adverse event reports for ADALIMUMAB.
1,663
Reports of Pulmonary embolism with ADALIMUMAB
0.3%
of all ADALIMUMAB reports
222
Deaths
1,116
Hospitalizations
How Dangerous Is Pulmonary embolism From ADALIMUMAB?
Of the 1,663 reports, 222 (13.3%) resulted in death, 1,116 (67.1%) required hospitalization, and 378 (22.7%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ADALIMUMAB.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
DROSPIRENONE\ETHINYL ESTRADIOL (1,295)
Which ADALIMUMAB Alternatives Have Lower Pulmonary embolism Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB